Soligenix Inc. [SNGX] shares are up more than 126.73% this year and recently increased 0.08% or $0.2 to settle at $2.49. Analysts expect SNGX to grow earnings at a 1.00% annual rate over the next 5 years. SNGX has a short ratio of 1.40. This implies that the market is currently less bullish on the outlook for SNGX.
On 17, November 2020, Pfizer and Moderna COVID-19 Vaccine Candidates Are Promising, but Soligenix’s Civax (TM) May Be a Better Alternative. According to news published on Yahoo Finance, New York, New York–(Newsfile Corp. – November 17, 2020) – Enthusiasm is surrounding Pfizer’s and Moderna’s announcement of COVID-19 vaccine candidates that may soon become ripe for approval. But, in all fairness to the progress, tempering some of the excitement is warranted.
Analyst Birdseye View:
The most recent analyst activity for Soligenix Inc. [NASDAQ:SNGX] stock was on January 31, 2018, when it was Downgrade with a Neutral rating from H.C. Wainwright, which also lowered its 12-month price target on the stock from $5.50 to $2.70. On August 14, 2017, Maxim Group Reiterated a Buy rating and boosted its price target on this stock from $4 to $5. On July 17, 2017, H.C. Wainwright Initiated a Buy rating and increased its price target to $11.
In the past 52 weeks of trading, this stock has oscillated between a low of $0.98 and a peak of $3.54. Right now, according to Wall Street analyst the average 12-month amount target is $4.31. At the most recent market close, shares of Soligenix Inc. [NASDAQ:SNGX] were valued at $2.49.
Soligenix Inc. [NASDAQ:SNGX] most recently reported quarterly sales of 507.2 million, which represented growth of -53.80%. This publicly-traded organization’s revenue is $200,977 per employee, while its income is -$584,724 per employee. This company’s Gross Margin is currently 20.50%, its Pretax Margin is -296.45, and its Net Margin is -290.94. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -102.43, -241.83, -281.98 and -241.64 respectively.
If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 8.03 and the whole liability to whole assets at 1.64. It shows enduring liability to the whole principal at 0.39 and enduring liability to assets at 0.00 while looking for an extended time period.
Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 2.24 points at 1st support level, the second support level is making up to 2.20. But as of 1st resistance point, this stock is sitting at 2.34 and at 2.40 for 2nd resistance point.
Soligenix Inc. [SNGX] reported its earnings at -$0.06 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.11/share signifying the difference of 0.05 and 45.50% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.1 calling estimates for -$0.13/share with the difference of 0.03 depicting the surprise of 23.10%.
Important Ratio’s To Watch
Meanwhile, turning our focus to liquidity, the Current Ratio for Soligenix Inc. [NASDAQ:SNGX] is 2.30. Likewise, the Quick ratio is also the same, showing Cash ratio at 0.86. Now if looking for a valuation of this stock’s amount to sales ratio it’s 8.74 and it’s amount to book ratio is 21.65.